United States Influenza Vaccines Market Forecast 2020 - 2027

Report ID: 49761 | Published Date: Nov 2024 | No. of Page: 200 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1. Executive Summary

2. United States Influenza Vaccines Market Size & Analysis (2013 - 2027) 

3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 - 2027) 
3.1 Number of Children Vaccinated with Influenza Vaccines
3.2 Number of Adults Vaccinated with Influenza Vaccines

4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market
4.1 Market Drivers
4.2 Market Restraints

5. United States Influenza Vaccines Pricing Trends & Analysis

6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies) 

7. United States Influenza Vaccines Distribution & Demand (2010 - 2020) 

8. Effectiveness of Influenza Vaccines in the United States (2004 – 2020) 

9. Rapid Diagnostic Testing for the Management of Influenza

10. Distribution Channel & Technique of Influenza Vaccination in the United States

11. Reimbursement Environment of the United States Influenza Vaccines Market

12. Regulatory Framework of the United States Influenza Vaccines Market

13. Major Deals and Agreement Happenings in the Influenza Vaccines Market
13.1 Merger & Acquisitions
13.2 Collaboration Deal
13.3 Licensing Agreement
13.4 Exclusive Agreement
13.5 Distribution Agreement

14. Promising Influenza Vaccines in the Clinical Development

15. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
15.1 Year 2020
15.2 Year 2019

16. Key Players Analysis
16.1 Sanofi Pasteur
16.1.1 Business Overview
16.1.2 Influenza Vaccines Portfolio
16.1.3 Influenza Vaccines Sales Value Analysis
16.1.4 Promising Influenza Vaccines in the Clinical Development
16.1.5 Recent Development
16.2 GlaxoSmithKline (GSK) 
16.2.1 Business Overview
16.2.2 Influenza Vaccines Portfolio
16.2.3 Influenza Vaccines Sales Value Analysis
16.2.4 Recent Development
16.3 Seqirus
16.3.1 Business Overview
16.3.2 Influenza Vaccines Portfolio
16.3.3 Influenza Vaccines Sales Value Analysis
16.3.4 Promising Influenza Vaccines in the Clinical Development
16.3.5 Recent Development
16.4 AstraZeneca
16.4.1 Business Overview
16.4.2 Influenza Vaccines Portfolio
16.4.3 Influenza Vaccines Sales Value Analysis
16.4.4 Recent Development

17. Emerging Players Analysis
17.1 Novavax
17.1.1 Business Overview
17.1.2 Promising Influenza Vaccines in the Clinical Development
17.1.3 Recent Development
17.2 BiondVax Pharmaceuticals Ltd. 
17.2.1 Business Overview
17.2.2 Promising Influenza Vaccines in the Clinical Development
17.2.3 Recent Development
17.3 Medicago
17.3.1 Business Overview
17.3.2 Promising Influenza Vaccines in the Clinical Development
17.3.3 Recent Development
17.4 Moderna Inc
17.4.1 Business Overview
17.4.2 Promising Influenza Vaccines in the Clinical Development
17.4.3 Recent Development
17.5 Pneumagen
17.5.1 Business Overview
17.5.2 Promising Influenza Vaccines in the Clinical Development
17.5.3 Recent Development
17.6 Altimmune
17.6.1 Business Overview
17.6.2 Promising Influenza Vaccines in the Clinical Development
17.6.3 Recent Development
17.7 Daiichi Sankyo
17.7.1 Business Overview
17.7.2 Promising Influenza Vaccines in the Clinical Development
17.7.3 Recent Development
17.8 FluGen
17.8.1 Business Overview
17.8.2 Promising Influenza Vaccines in the Clinical Development
17.8.3 Recent Development
17.9 Imutex
17.9.1 Business Overview
17.9.2 Promising Influenza Vaccines in the Clinical Development
17.9.3 Recent Development


List of Tables:

Table 5–1: United States Pediatric Influenza Vaccines Price, 2020 – 2021
Table 5–2: United States Adult Influenza Vaccine Price, 2020 – 2021
Table 6–1: United States Influenza Vaccines Production, Supply, and Allocation
Table 7–1: Total Percentage of Influenza Vaccines Released by Week, 2019 – 2020
Table 7–2: Total Percentage of Influenza Vaccines Released by Week,2018 – 2019
Table 7–3: Total Percentage of Influenza Vaccines Released by Week,2017 – 2018
Table 7–4: Total Percentage of Influenza Vaccines Released by Week,2016 – 2017
Table 7–5: Total Percentage of Influenza Vaccines Released by Week,2015 – 2016
Table 7–6: Total Percentage of Influenza Vaccines Released by Week,2014 – 2015
Table 8–1: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2004 – 2020
Table 9–1: Influenza Virus Testing Methods
Table 10–1: Distribution of Influenza Vaccination
Table 12–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 13–1: Merger & Acquisitions in the Influenza Vaccines Market
Table 13–2: Collaboration Deal in the Influenza Vaccines Market
Table 13–3: Licensing Agreement in the Influenza Vaccines Market
Table 13–4: Exclusive Agreement in the Influenza Vaccines Market
Table 13–5: Distribution Agreement in the Influenza Vaccines Market
Table 14–1: BiondVax Pharmaceuticals Ltd. – Clinical Trials
Table 16–1: Sanofi Pasteur Promising Influenza Vaccines in the Clinical Development
Table 16–2: Seqirus Promising Influenza Vaccines in the Clinical Development
Table 17–1: Novavax Promising Influenza Vaccines in the Clinical Development
Table 17–2: Biondvax Promising Influenza Vaccines in the Clinical Development
Table 17–3: Medicago Promising Influenza Vaccines in the Clinical Development
Table 17–4: Moderna Promising Influenza Vaccines in the Clinical Development
Table 17–5: Pneumagen Promising Influenza Vaccines in the Clinical Development
Table 17–6: Altimmune Promising Influenza Vaccines in the Clinical Development
Table 17–7: Daiichi Sankyo Promising Influenza Vaccines in the Clinical Development
Table 17–8: FluGen Promising Influenza Vaccines in the Clinical Development
Table 17–9: Imutex Promising Influenza Vaccines in the Clinical Development


List of Figures:

Figure 2–1: United States Influenza Vaccines Market (Million US$),2013 – 2019
Figure 2–2: United States Influenza Vaccines Market Forecast (Million US$),2020 – 2027
Figure 3–1: United States Total Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2019
Figure 3–2: United States Total Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2020 – 2027
Figure 3–3: United States Number of Children Vaccinated with Influenza Vaccines (Thousand),2013 – 2019
Figure 3–4: United States Number of Children Vaccinated with Influenza Vaccines Forecast (Thousand),2020 – 2027
Figure 3–5: United States Number of Adults Vaccinated with Influenza Vaccines (Thousand),2013 – 2019
Figure 3–6: United States Number of Adults Vaccinated with Influenza Vaccines Forecast (Thousand),2020 – 2027
Figure 7–1: United States Influenza Vaccine Doses Distributed, By Season (Million),2010 – 2020
Figure 10–1: United States Place of Influenza Vaccination for Children and Adults (Percent),2018 - 2019
Figure 16–1: Sanofi Pasteur Influenza Vaccines Net Sales Value (Million US$),2013 – 2019
Figure 16–2: Sanofi Pasteur Influenza Vaccines Net Sales Value Forecast (Million US$),2020 – 2027
Figure 16–3: GSK Influenza Vaccines Net Sales Value (Million US$),2013 – 2019
Figure 16–4: GSK Influenza Vaccines Net Sales Value Forecast (Million US$),2020 – 2027
Figure 16–5: Seqirus Influenza Vaccines Net Sales Value (Million US$),2015 – 2019
Figure 16–6: Seqirus Influenza Vaccines Net Sales Value Forecast (Million US$),2020 – 2027
Figure 16–7: AstraZeneca Influenza Vaccines Net Sales Value (Million US$),2013 – 2019
Figure 16–8: AstraZeneca Influenza Vaccines Net Sales Value Forecast (Million US$),2020 – 2027
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
United States Influenza Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
United States Influenza Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
United States Influenza Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports